AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18975051
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of iopamidol 300 at an injection rate of 3.7 ml/s
Trial: 18975051
Drug: 80 ml
RxNorm normalized name: urinary bag 480 mL MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 ml of iopamidol 370 at an injection rate of 3.0 ml/s
Trial: 16637481
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group IN (MOD inlay preparation)
Trial: 11304641
Drug: CODAS verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CODAS verapamil PM 200 mg dosed nightly
Trial: 11304641
Drug: Immediate‐acting verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate‐acting verapamil 80 mg dosed three times daily
Trial: 11304641
Drug: Both medications
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both medications tested
Trial: 8630717
Drug: Acrivastine 8
RxNorm normalized name: acrivastine 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acrivastine 8 mg plus pseudoephedrine HCl 60 mg
Trial: 1450287
Drug: Physostigmine (anticholinesterase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine (anticholinesterase inhibitor)
Trial: 2858839
Drug: Regular interval
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular interval (RI) group - buprenorphine 0.3 mg IV before anaesthesia, followed by sublingual buprenorphine 0.4 mg 6 hourly postoperatively
Trial: 2858839
Drug: On demand
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On demand (OD) group - meperidine 1 mg/kg on demand in recovery room, followed by ketobemidone 5 mg subcutaneously on demand
Trial: 31340846
Drug: Active abdominal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active abdominal functional electrical stimulation (FES) for 30 minutes, twice per day, 5 days per week until ICU discharge.
Trial: 31340846
Drug: Sham (control)
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham (control) abdominal functional electrical stimulation for 30 minutes, twice per day, 5 days per week until ICU discharge.
Trial: 20225533
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with subcutaneous injections of Dp and Df extracts
Trial: 18627266
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg annual zoledronate (n = 17)
Trial: 15040821
Drug: Low-magnitude, high-frequency
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-magnitude, high-frequency mechanical stimuli (vibration) - 2.0 m/s2 peak to peak, 30 Hz, two 10-minute treatments/day
Trial: 11048608
Drug: Third-generation aromatase
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third-generation aromatase inhibitors
Trial: 11562748
Drug: Anti-HER2 monoclonal
RxNorm normalized name: Recombinant humanized IgG1 anti-HER2 monoclonal antibody conjugated to Duostatin-5
DrugBank: A166 (DB17413)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-HER2 monoclonal antibody Trastuzumab
Trial: 2897172
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline, 0.03 ml/kg)
Trial: 12684609
Drug: Risperidone (4-8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (4-8 mg/day)
Trial: 24021217
Drug: Escitalopram (SSRI)
DrugBank: Escitalopram (DB01175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Escitalopram (SSRI) with low-transcription 1A receptor genotype
Trial: 24021217
Drug: Escitalopram (SSRI)
DrugBank: Escitalopram (DB01175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Escitalopram (SSRI) with high-expressing genotypes in serotonin transporter, 1A, or 2A receptors
Trial: 17692137
Drug: Fermented milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermented milk with probiotics and inulin (4 g)
Trial: 15958324
Drug: Complex Hongyibuxue
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex Hongyibuxue oral solution
Trial: 9698951
Drug: Ketorolac 1
RxNorm normalized name: ketorolac 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 1 mg.kg-1 i.v. preoperative
Trial: 9698951
Drug: Ketorolac 1
RxNorm normalized name: ketorolac 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 1 mg.kg-1 i.v. postoperative
Trial: 2240674
Drug: 400-micrograms clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 400-micrograms clonidine bolus followed by 10 micrograms/h clonidine infusion
Trial: 2240674
Drug: 800-micrograms clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 800-micrograms clonidine bolus followed by 20 micrograms/h clonidine infusion
Trial: 2240674
Drug: Saline bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline bolus followed by 24-h saline infusion
Trial: 2240674
Drug: 20 micrograms/h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms/h clonidine infusion
Trial: 25841300
Drug: Saxagliptin-metformin
RxNorm normalized name: metformin / saxagliptin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saxagliptin-metformin
Trial: 25841300
Drug: Acarbose-metformin
RxNorm normalized name: Acarbose
DrugBank: Acarbose (DB00284)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acarbose-metformin
Trial: 21354682
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate (1 tablet containing 1,000 mg of elemental lanthanum)
Trial: 21354682
Drug: Sevelamer carbonate
RxNorm normalized name: Sevelamer Carbonate
DrugBank: Sevelamer (DB00658)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevelamer carbonate (three 800-mg tablets)
Trial: 17069768
Drug: Prazosin (13.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (13.3 +/- 3 mg/day)
Trial: 16551154
Drug: Cognitive‐behavioral group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioral group therapy
Trial: 15279523
Drug: Exposure group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure group therapy without explicit cognitive interventions
Trial: 9506731
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg prednisolone daily for 3.7 +/- 0.6 months (range, 1-6)
Trial: 30580089
Drug: Supervised Pelvic
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised Pelvic Floor Muscle Training (PFMT) and biofeedback plus conservative treatment
Trial: 30580089
Drug: Attention-control massage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Attention-control massage treatment plus conservative treatment
Trial: 28735217
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses (5mg and 10mg zopiclone)
Trial: 21804212
Drug: Silodosin 2
RxNorm normalized name: Silodosin
DrugBank: Silodosin (DB06207)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Silodosin 2 mg
Trial: 21571345
Drug: Silodosin 4
RxNorm normalized name: silodosin 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silodosin 4 mg
Trial: 21804212
Drug: Silodosin 12
RxNorm normalized name: Silodosin
DrugBank: Silodosin (DB06207)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Silodosin 12 mg
Trial: 21804212
Drug: Silodosin 4
RxNorm normalized name: silodosin 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silodosin 4 mg (multiple dosing)
Trial: 16404360
Drug: Carboplatin (AUC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (AUC 7) followed by docetaxel 100 mg/m² (arm A)
Trial: 16404360
Drug: Docetaxel 60
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 60 mg/m² with irinotecan 200 mg/m² (arm B)
Trial: 8034840
Drug: Adrenalized solutions
RxNorm normalized name: adrenal cortex extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenalized solutions (with epinephrine 1:200,000)
Trial: 19564260
Drug: Nonstudy antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonstudy antibiotics
Trial: 12776814
Drug: Antiprex (Elpen,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiprex (Elpen, Greece) 20 mg
Trial: 12776814
Drug: Renitec (Vianex,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renitec (Vianex, Greece) 20 mg
Trial: 8831919
Drug: Ciprofibrate, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofibrate, 100 mg/day once daily
Trial: 8831919
Drug: Gemfibrozil, 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil, 1200 mg/day twice daily
Trial: 1314922
Drug: Plain cardioplegic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain cardioplegic solution
Trial: 3893007
Drug: sc human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sc human growth hormone
Trial: 3893007
Drug: im growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: im growth hormone therapy
Trial: 9675959
Drug: Carvedilol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (50 mg/day)
Trial: 31343094
Drug: ETC-206, an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETC-206, an oral Mnk 1/2 kinase inhibitor
Trial: 30665869
Drug: Ramucirumab (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramucirumab (8 mg/kg IV every 2 weeks)
Trial: 26048277
Drug: Ramucirumab (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramucirumab (8 mg/kg IV every 2 weeks) + Paclitaxel (80 mg/m² on days 1, 8, and 15 of 28-day cycles)
Trial: 16713143
Drug: Conventional-dose HT
RxNorm normalized name: 5-HT
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional-dose HT (2 mg 17beta-estradiol + 1 mg NETA)
Trial: 16713143
Drug: Low-dose HT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose HT (1 mg 17beta-estradiol + 0.5 mg NETA)
Trial: 11282903
Drug: Intracoronary insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary insulin infusion
Trial: 9272389
Drug: Lansoprazole plus
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lansoprazole plus amoxicillin
Trial: 3060612
Drug: Ketoprofen (200-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (200-300 mg/day)
Trial: 3060612
Drug: Indomethacin (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (100-150 mg/day)
Trial: 3060612
Drug: Ketoprofen (200-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (200-300 mg/day) and Indomethacin (100-150 mg/day)
Trial: 27922028
Drug: Lubiprostone (48
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lubiprostone (48 mcg per day)
Trial: 21218307
Drug: Consistent methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Consistent methadone treatment
Trial: 21218307
Drug: Skills for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skills for avoiding and refusing drugs, coping with stress, and maintaining recovery-supportive friendships
Trial: 17027436
Drug: Oily fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oily fish (4.5 g eicosapentaenoic acid + docosahexanoic acid)
Trial: 17027436
Drug: White fish
RxNorm normalized name: WHITE FISH
DrugBank: White fish (DB10627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White fish (0.7 g eicosapentaenoic acid + docosahexanoic acid)
Trial: 12717871
Drug: Asthma medication
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Asthma medication including inhaled salbutamol 200 microg four times a day and budesonide 400 microg twice a day for 6 weeks
Trial: 12717871
Drug: Asthma medication
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Asthma medication plus antireflux therapy including oral omeprazole 20 mg once a day and domperidone 10 mg three times a day for 6 weeks
Trial: 11157692
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIG) 1 g/kg on days 1 and 2 and 0.4 g/kg on days 14 and 28
Trial: 7903211
Drug: Tertatolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tertatolol (5 mg)
Trial: 7903211
Drug: Tertatolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tertatolol (5 mg) and Prazosin (1 mg)
Trial: 3425213
Drug: Lorazepam 1
RxNorm normalized name: lorazepam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 1 mg FDDF
Trial: 3425213
Drug: Lorazepam 2
RxNorm normalized name: lorazepam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 2 mg FDDF
Trial: 21255627
Drug: 1% whey
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% whey protein beverage (5 g, 93 kJ)
Trial: 21255627
Drug: 2% whey
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% whey protein beverage (10 g, 178 kJ)
Trial: 21255627
Drug: 4% whey
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% whey protein beverage (20 g, 348 kJ)
Trial: 19505883
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy plus CRT
Trial: 9427903
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin A therapy
Trial: 8487050
Drug: Hyperfractionated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiation therapy and carmustine (BCNU)
Trial: 3301079
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg intravenous dose of captopril
Trial: 3301079
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg intravenous dose of captopril
Trial: 3301079
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg intravenous dose of captopril
Trial: 31950979
Drug: Intravenous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vitamin C (1.5 g every 6 hours), hydrocortisone (50 mg every 6 hours), and thiamine (200 mg every 12 hours)
Trial: 31950979
Drug: Intravenous hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous hydrocortisone (50 mg every 6 hours) alone
Trial: 27832548
Drug: 6.4% maltodextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.4% maltodextrin solution with sweetener (CHO)
Trial: 24374357
Drug: Phonophoresis (PP)
RxNorm normalized name: propoxyphene hydrochloride Oral Capsule [PP-Cap]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phonophoresis (PP) with capsaicin treatment and exercises
Trial: 19020160
Drug: Bupivacaine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine infusion above the fascia (group AF, n = 29)
Trial: 19020160
Drug: Bupivacaine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine infusion below the fascia (group BF, n = 31)
Trial: 15897784
Drug: Carvedilol therapy
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol therapy (group 1)
Trial: 21094838
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (group 2)
Trial: 1280862
Drug: Heparin (5,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (5,000 IU i.v.)
Trial: 6703348
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (all doses)
Trial: 24503279
Drug: Methylphenidate as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate as add-on therapy to mirtazapine
Trial: 24503279
Drug: Placebo as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo as add-on therapy to mirtazapine
Trial: 19188136
Drug: Cetuximab (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (400 mg/m² day 1 followed by weekly 250 mg/m²) + paclitaxel (225 mg/m²)/carboplatin (AUC6) day 1 every 3 weeks
Trial: 19188136
Drug: Cetuximab (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (400 mg/m² day 1 followed by weekly 250 mg/m²) + paclitaxel (100 mg/m²) days 1, 8, and 15 every 3 weeks and carboplatin (AUC6) day 1 every 4 weeks
Trial: 15970000
Drug: Luteal FSH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luteal FSH suppression by physiological oestradiol doses
Trial: 15970000
Drug: Luteal oestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luteal oestradiol administration
Trial: 15970000
Drug: Premenstrual GnRH
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Premenstrual GnRH antagonist administration
Trial: 12532716
Drug: Concomitant radio-chemotherapy
RxNorm normalized name: Valerianae radix
DrugBank: Valerian (DB13196)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant radio-chemotherapy
Trial: 9881328
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg of conjugated equine estrogen (CEE) daily (group 1)
Trial: 9881328
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg of conjugated equine estrogen (CEE) daily (group 2)
Trial: 3396459
Drug: Auxiliary prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auxiliary prescription labels (study sticker)
Trial: 3396459
Drug: No auxiliary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No auxiliary prescription labels (control group)
Trial: 31758556
Drug: TAU +
RxNorm normalized name: Interferon tau
DrugBank: Interferon tau (DB16972)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAU + 7 weekly 90-minute sessions of AF-EMDR (N = 55)
Trial: 29567761
Drug: Subcutaneous IL-1
RxNorm normalized name: IL-1 TRAP
DrugBank: Rilonacept (DB06372)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous IL-1 receptor antagonist (IL-1Ra) 100 mg administered twice daily for 3 days
Trial: 21923854
Drug: Modified constraint‐induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified constraint‐induced therapy (mitt on the unaffected hand for 2 hours each day for 8 weeks)
Trial: 21923854
Drug: Intensive occupational
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive occupational therapy (8 weeks)
Trial: 19144261
Drug: Olopatadine HCl
RxNorm normalized name: olopatadine HCl
DrugBank: Olopatadine (DB00768)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olopatadine HCl nasal spray 0.6% (OLO)
Trial: 10976548
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine (21 mg patch)
Trial: 1404796
Drug: Magnesium chloride,
RxNorm normalized name: Magnesium Chloride, Injectable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium chloride, 2 g intravenous infusion
Trial: 4003371
Drug: Cefoxitin antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin antibiotic prophylaxis
Trial: 29598955
Drug: Weight gain
RxNorm normalized name: Nutritional Supplement Oral Powder for Suspension [MUSCLE & WEIGHT GAINER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight gain during chemotherapy (≥ 5% increase)
Trial: 29598955
Drug: Weight loss
RxNorm normalized name: HERBAL WEIGHT LOSS AID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight loss during chemotherapy (≥ 5% decrease)
Trial: 29598955
Drug: Stable weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stable weight during chemotherapy
Trial: 15921758
Drug: 0.59‐mg fluocinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.59‐mg fluocinolone acetonide intravitreal implant
Trial: 15921758
Drug: 2.1‐mg fluocinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.1‐mg fluocinolone acetonide intravitreal implant
Trial: 12358873
Drug: Continuous combined
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous combined hormone replacement therapy (n = 29) with conjugated equine oestrogen (0.625 mg/day) plus medroxyprogesterone acetate (2.5 mg/day)
Trial: 10415739
Drug: Subantimicrobial dose
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subantimicrobial dose of doxycycline (SDD)
Trial: 2105538
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) 100 mg daily for 2 months
Trial: 473929
Drug: Intraarticular administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraarticular administration of 125 mg/0.5 ml Arteparon (6 injections)
Trial: 473929
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration of 125 mg/0.5 ml Arteparon (10 injections)
Trial: 473929
Drug: Intraarticular and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular and Intramuscular administration of Arteparon